Research
Hormonal
Resistance training performed three times per week significantly improves glycemic control (HbA1c) in older adults with type 2 diabetes, comparable to aerobic exercise.
Add resistance training to your routine three days a week. Focus on major muscle groups, doing 3 sets of 8-10 reps with a weight that feels challenging but manageable. This significantly lowers blood sugar and is safe even if you have heart disease risk factors. Start with supervision to ensure proper form.
WeakSupportsVERY_HIGH confidence
In both studies, the average age of participants was 66 years, and the resistance-training regimen involved multiple exercises at high intensity (three sets, three times per week), and absolute A1C declined 1.1–1.2% in resistance-training subjects versus no significant change in control subjects.
Why this rating
Based on two clinical trials providing the strongest evidence (Level of Evidence A).
Source
Physical Activity/Exercise and Type 2 Diabetes
Ronald J. Sigal et al. · Diabetes Care · 2006
DOI 10.2337/dc06-9910
clinical_guidelineCited 952×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Structured aerobic exercise of at least 150 minutes per week significantly improves glycemic control (HbA1c) in individuals with type 2 diabetes, independent of weight loss.Weak
- Lifestyle interventions combining at least 150 minutes per week of physical activity with modest energy restriction reduce the risk of progression from impaired glucose tolerance (IGT) to type 2 diabetes by 58%.Weak
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →